Lataa...
Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone
Current interventions to reduce skeletal fragility are insufficient at enhancing both the quantity and quality of bone when attempting to improve overall mechanical integrity. Bisphosphonates, such as Zoledronate (ZOL), are used to treat a variety of bone disorders by increasing bone mass to decreas...
Tallennettuna:
| Julkaisussa: | Bone |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7036744/ https://ncbi.nlm.nih.gov/pubmed/31233931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2019.06.018 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|